Αποτελέσματα Αναζήτησης
4 Σεπ 2023 · The presence of hypocalcemia, hyperphosphatemia, normal 25 hydroxyvitamin D, and elevated parathyroid hormone levels suggest pseudohypoparathyroidism. A synthetic PTH challenge test can be performed (Ellsworth-Howard test) but is not necessary for diagnosis.
Hereditary condition clinically resembling hypoparathyroidism, but caused by failure of response to rather than deficiency of parathyroid hormones; characterized by hypocalcemia and hyperphosphatemia, and commonly associated with short stature, obesity, short metacarpals, and ectopic calcification.
15 Ιουλ 2022 · Pseudohypoparathyroidism results from resistance to the actions of parathyroid hormone (PTH) produced by a loss of G-protein-mediated signalling. Different types are distinguished by the presence or absence of a characteristic skeletal phenotype, the responsiveness to PTH, the underlying mutation...
This Consensus Statement covers recommendations for the diagnosis and management of patients with pseudohypoparathyroidism (PHP) and related disorders, which comprise metabolic disorders characterized by physical findings that variably include short bones, short stature, a stocky build, early-onset ….
29 Ιουν 2018 · This Consensus Statement covers recommendations for the diagnosis and management of patients with pseudohypoparathyroidism (PHP) and related disorders, which comprise metabolic disorders...
Today the term pseudohypoparathyroidism (OMIM 103580 for PHP1A, 603233 for PHP1B, and 612462 for PHP type 1C [PHP1C]) describes disorders that share biochemical characteristics of hypoparathyroidism, i.e., hypocalcemia and hyperphosphatemia, as a result of proximal tubular resistance to PTH.
E20.1 is a billable diagnosis code used to specify a medical diagnosis of pseudohypoparathyroidism. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2024 through September 30, 2025.
